438 results on '"Simona Bungau"'
Search Results
2. An extensive pharmacological evaluation of novel anti-nociceptive and IL-6 targeted anti-inflammatory guaiane-type sesquiterpenoids from Cinnamomum migao H. W. Li through in-depth in-vitro, ADMET, and molecular docking studies
- Author
-
Ishaq Muhammad, Syed Shams ul Hassan, Wen-Jing Xu, Guo-Li Tu, Hua-Jun Yu, Xue Xiao, Shi-Kai Yan, Hui-Zi Jin, and Simona Bungau
- Subjects
Cinnamomum migao H. W. Li ,Guaiane-sesquiterpenoids ,Anti-inflammatory activity ,Anti-nociceptive effect ,ADMET ,Molecular dynamic simulations ,Therapeutics. Pharmacology ,RM1-950 - Abstract
Guaiane-type sesquiterpenoids are most prevalent in the genus Cinnamomum. Hence this study investigates the structures, anti-nociceptive and IL-6 targeted anti-inflammatory potential of three novels C-14 guaiane-type sesquiterpenoids and two new monoterpenoids, isolated from Cinnamomum migao. The structures were precisely confirmed and characterized through the modern chromatographic and spectroscopic techniques of HRESIMS, 1D NMR, 2D NMR, experimental circular dichroism (ECD), and calculated (ECD). Novel sesquiterpenoids 1 and 2 exhibited significant anti-inflammatory activities against the NO production and pro-inflammatory cytokines. Their IC50 values were determined as 9.52 and 13.42 μΜ against IL-6 mRNA, respectively. Similarly, subcutaneous injection of n-BuT and EA extracts showed a dose-dependent suppression of formalin-induced tonic biting/licking responses during the tonic antinociceptive phase. Furthermore, absorption, distribution, metabolism, excretion, and toxicity (ADMET) analysis of guaiane-type sesquiterpenoids 1 and 2 displayed that both compounds have a high level of GIT absorption, with a high zone of safety for cardiac and hepatotoxicity and no inhibition of cytochromes. In addition, molecular docking and simulation studies strengthen the anti-inflammatory potential of sesquiterpene 2 which showed a good binding affinity with IL-6 protein. Overall the inclusive results showed that the extracts and newly isolated guaiane-type sesquiterpenoids from C. migao will provide new evidence for the traditional use of this species to treat inflammation and nociception.
- Published
- 2023
- Full Text
- View/download PDF
3. Genome-wide Meta-analysis Reveals New Gene Signatures and Potential Drug Targets of Hypertension
- Author
-
Fawad Ali, Arifullah Khan, Syed Aun Muhammad, Syed Qamar Abbas, Syed Shams ul Hassan, and Simona Bungau
- Subjects
Chemistry ,QD1-999 - Published
- 2022
- Full Text
- View/download PDF
4. Reprogramming tumor-associated macrophages as a unique approach to target tumor immunotherapy
- Author
-
Safir Ullah Khan, Munir Ullah Khan, Muhammad Azhar Ud Din, Ibrar Muhammad Khan, Muhammad Imran Khan, Simona Bungau, and Syed Shams ul Hassan
- Subjects
tumor-associated macrophages ,anti-cancer treatment ,immune suppression ,Metabolism ,macrophage-targeting immunotherapy ,Immunologic diseases. Allergy ,RC581-607 - Abstract
In the last ten years, it has become increasingly clear that tumor-infiltrating myeloid cells drive not just carcinogenesis via cancer-related inflammatory processes, but also tumor development, invasion, and metastasis. Tumor-associated macrophages (TAMs) in particular are the most common kind of leucocyte in many malignancies and play a crucial role in establishing a favorable microenvironment for tumor cells. Tumor-associated macrophage (TAM) is vital as the primary immune cell subset in the tumor microenvironment (TME).In order to proliferate and spread to new locations, tumors need to be able to hide from the immune system by creating an immune-suppressive environment. Because of the existence of pro-tumoral TAMs, conventional therapies like chemotherapy and radiotherapy often fail to restrain cancer growth. These cells are also to blame for the failure of innovative immunotherapies premised on immune-checkpoint suppression. Understanding the series of metabolic changes and functional plasticity experienced by TAMs in the complex TME will help to use TAMs as a target for tumor immunotherapy and develop more effective tumor treatment strategies. This review summarizes the latest research on the TAMs functional status, metabolic changes and focuses on the targeted therapy in solid tumors.
- Published
- 2023
- Full Text
- View/download PDF
5. Effect of dietary probiotics on intestinal microbiota in patients with Crohn’s disease
- Author
-
Flavia M. PAVEL, Delia M. TIT, Alexa F. BUNGAU, Tapan BEHL, Alexandra G. TARCE, and Simona BUNGAU
- Subjects
gastrointestinal disorders ,crohn’s disease ,gut microbiome ,Medicine ,Medicine (General) ,R5-920 - Abstract
Introduction. Probiotics are well-known adjuvants, used as complementary therapeutic agents in health (e.g. gastrointestinal or metabolic) disorders, considering their beneficial role on gut microbiota, and their support in immunity. The objective of the study was to evaluate the impact of probiotic supplementation on abundance of Bacteroides spp. in intestinal microbiome of patients with Crohn’s disease (CD). Materials and methods. The comparative evaluation was conducted over a 6-month period, on 49 subjects diagnosed with CD, who were separated into two groups, as follows: the study group (probiotics associated with allopathic treatment) and the control group (only allopathic treatment). All patients were evaluated at baseline and at 6 months. Demographic characteristics, associated pathology, and the evolution of intestinal microbiome and faecal pH were followed. Results. In this research, the microbiome of patients with CD showed changes in the abundance of bacterial species. The combination of probiotic treatment led to the following changes: Escherichia coli (from 5.77×107 to 4.15×107, p=0.006) and Enterobacter spp. (from 1.92×104 to 1.17×104, p=0.009) values decreased significantly and Faecalibacterium prausnitzii (from 3.73×108 to 4.55×108, p=0.003), Bifidobacterium spp. (from 4.76×106 to 4.92×106, p
- Published
- 2022
- Full Text
- View/download PDF
6. A Comprehensive Review of Biological Roles and Interactions of Cullin‑5 Protein
- Author
-
Iqra Bano, Anum Sumera Soomro, Syed Qamar Abbas, Amirhossein Ahmadi, Syed Shams ul Hassan, Tapan Behl, and Simona Bungau
- Subjects
Chemistry ,QD1-999 - Published
- 2022
- Full Text
- View/download PDF
7. Emodin alleviates chronic constriction injury-induced neuropathic pain and inflammation via modulating PPAR-gamma pathway.
- Author
-
Ismail Badshah, Neelum Gul Qazi, Fawad Ali, Amber Mahmood Minhas, Arooj Mohsin Alvi, Mahmoud Kandeel, Muhammad Imran, Syed Shams Ul Hassan, and Simona Bungau
- Subjects
Medicine ,Science - Abstract
Neuropathic pain has been characterized as chronic pain resulting from pathological damage to the sensorimotor system. Because of its complex nature, it remains refractory to most of the therapeutic interventions, and surgical intervention and physiotherapy alongside steroidal treatments remain the only treatment protocols with limited success, hence solidifying the need to find efficacious therapeutic alternatives. Emodin was used as a post-treatment for its potential to be neuroprotective in the treatment of chronic constriction injury-induced NP. The first day following surgery, Emodin treatment began, and it lasted until the 21st day. On days 3, 7, 14 and 21, all behavioral investigations were conducted. The sciatic nerve and spinal cord were extracted for further molecular examination. Emodin elevated response latency, was able to delay the onset of mechanical hyperalgesia in rats on days 7, 14, and 21 and reduced the CCI-induced paw deformation. Emodin treatment significantly reduced lipid peroxidation and NO levels while restoring the GST, GSH and catalase. It significantly improved the disorientation of the sciatic nerve and spinal cord confirmed by H & E staining and reduced inflammatory markers as observed by the quantification of COX-2, TNF-α, p-NFκb and up-regulated PPAR-γ levels by ELISA and PCR. According to the findings, Emodin has antinociceptive and anti-hyperalgesic properties, which reduced pain perception and inflammation. We also suggested the involvement of PPAR-γ pathway in the therapeutic potential of emodin in chronic nerve injury.
- Published
- 2023
- Full Text
- View/download PDF
8. Evaluation of cell adhesion and osteoconductivity in bone substitutes modified by polydopamine
- Author
-
Ali Mahnavi, Mina Shahriari-Khalaji, Bahareh Hosseinpour, Mostafa Ahangarian, Amir Aidun, Simona Bungau, and Syed Shams ul Hassan
- Subjects
biomaterials ,scaffold ,tissue engineering ,bone ,polydopamine ,surface modification ,Biotechnology ,TP248.13-248.65 - Abstract
Bones damaged due to disease or accidents can be repaired in different ways. Tissue engineering has helped with scaffolds made of different biomaterials and various methods. Although all kinds of biomaterials can be useful, sometimes their weakness in cellular activity or osteoconductivity prevents their optimal use in the fabrication of bone scaffolds. To solve this problem, we need additional processes, such as surface modification. One of the common methods is coating with polydopamine. Polydopamine can not only cover the weakness of the scaffolds in terms of cellular properties, but it can also create or increase osteoconductivity properties. Polydopamine creates a hydrophilic layer on the surface of scaffolds due to a large number of functional groups such as amino and hydroxyl groups. This layer allows bone cells to anchor and adheres well to the surfaces. In addition, it creates a biocompatible environment for proliferation and differentiation. Besides, the polydopamine coating makes the surfaces chemically active by catechol and amine group, and as a result of their presence, osteoconductivity increases. In this mini-review, we investigated the characteristics, structure, and properties of polydopamine as a modifier of bone substitutes. Finally, we evaluated the cell adhesion and osteoconductivity of different polydopamine-modified bone scaffolds.
- Published
- 2023
- Full Text
- View/download PDF
9. Metals-triggered compound CDPDP exhibits anti-arthritic behavior by downregulating the inflammatory cytokines, and modulating the oxidative storm in mice models with extensive ADMET, docking and simulation studies
- Author
-
Syed Shams ul Hassan, Syed Qamar Abbas, Ishaq Muhammad, Jia-Jia Wu, Shi-Kai Yan, Fawad Ali, Muhammad Majid, Hui-Zi Jin, and Simona Bungau
- Subjects
actinobacteria ,inflammation ,arthritis ,anti-oxidant ,admet ,molecular docking ,Therapeutics. Pharmacology ,RM1-950 - Abstract
Graphical Abstract
- Published
- 2022
- Full Text
- View/download PDF
10. Corrigendum: The neuroprotective effects of fisetin, a natural flavonoid in neurodegenerative diseases: Focus on the role of oxidative stress
- Author
-
Syed Shams ul Hassan, Saptadip Samanta, Raju Dash, Tomasz M. Karpiński, Emran Habibi, Abdul Sadiq, Amirhossin Ahmadi, and Simona Bungau
- Subjects
neurodegeneration ,flavonoid ,antioxidant ,oxidative strees ,fiestin ,Therapeutics. Pharmacology ,RM1-950 - Published
- 2022
- Full Text
- View/download PDF
11. Appraisal of selected ethnomedicinal plants as alternative therapies against onychomycosis: Evaluation of synergy and time-kill kinetics
- Author
-
Syeda Aroosa Mohsin, Shazia Shaukat, Marya Nawaz, Tofeeq Ur-Rehman, Nadeem Irshad, Muhammad Majid, Syed Shams ul Hassan, Simona Bungau, and Humaira Fatima
- Subjects
onychomycosis ,antifungal ,resistance ,synergistic studies ,HPLC ,Therapeutics. Pharmacology ,RM1-950 - Abstract
Introduction: This study aims at the biological profiling of Allium sativum, Zingiber officinale, Nigella sativa, Curcuma longa, Mentha piperita, Withania somnifera, Azadirachta indica, and Lawsonia inermis as alternatives against onychomycosis to combat the treatment challenges.Methods: An extract library of aqueous (DW), ethyl acetate (EA), and methanol (M) extracts was subjected to phytochemical and antioxidant colorimetric assays to gauge the ameliorating role of extracts against oxidative stress. RP-HPLC quantified therapeutically significant polyphenols. Antifungal potential (disc diffusion and broth dilution) against filamentous (dermatophytes and non-dermatophytes) and non-filamentous fungi (yeasts; Candida albicans), synergistic interactions (checkerboard method) with terbinafine and amphotericin-B against resistant clinical isolates of dermatophytes (Trichophyton rubrum and Trichophyton tonsurans) and non-dermatophytes (Aspergillus spp., Fusarium dimerum, and Rhizopus arrhizus), time-kill kinetics, and protein estimation (Bradford method) were performed to evaluate the potential of extracts against onychomycosis.Results: The highest total phenolic and flavonoid content along with noteworthy antioxidant capacity, reducing power, and a substantial radical scavenging activity was recorded for the extracts of Z. officinale. Significant polyphenolics quantified by RP-HPLC included rutin (35.71 ± 0.23 µg/mgE), gallic acid (50.17 ± 0.22 µg/mgE), catechin (93.04 ± 0.43 µg/mgE), syringic acid (55.63 ± 0.35 µg/mgE), emodin (246.32 ± 0.44 µg/mgE), luteolin (78.43 ± 0.18 µg/mgE), myricetin (29.44 ± 0.13 µg/mgE), and quercetin (97.45 ± 0.22 µg/mgE). Extracts presented prominent antifungal activity against dermatophytes and non-dermatophytes (MIC-31.25 μg/ml). The checkerboard method showed synergism with 4- and 8-fold reductions in the MICs of A. sativum, Z. officinale, M. piperita, L. inermis, and C. longa extracts and doses of amphotericin-B (Amp-B) and terbinafine (against non-dermatophytes and dermatophytes, respectively). Furthermore, the synergistic therapy showed a time-dependent decrease in fungal growth even after 9 and 12 h of treatment. The inhibition of fungal proteins was also observed to be higher with the treatment of synergistic combinations than with the extracts alone, along with the cell membrane damage caused by terbinafine and amp-B, thus making the resistant fungi incapable of subsisting.Conclusion: The extracts of A. sativum, Z. officinale, M. piperita, L. inermis, and C. longa have proven to be promising alternatives to combat oxidative stress, resistance, and other treatment challenges of onychomycosis.
- Published
- 2022
- Full Text
- View/download PDF
12. Pharmacological basis of bergapten in gastrointestinal diseases focusing on H+/K+ ATPase and voltage-gated calcium channel inhibition: A toxicological evaluation on vital organs
- Author
-
Huma Aslam, Arif-ullah Khan, Neelum Gul Qazi, Fawad Ali, Syed Shams ul Hassan, and Simona Bungau
- Subjects
bergapten ,gastroprotective ,anti-ulcer ,H/K ATPase ,calcium channel blocking ,acute toxicity ,Therapeutics. Pharmacology ,RM1-950 - Abstract
Aim and objectives: This study aimed to establish a pharmacological basis for evaluating the effects of bergapten (5-methoxypsoralen) in gastrointestinal diseases and assessment of its toxicological profile.Methods: The pharmacokinetic profile was evaluated using the SwissADME tool. AUTODOCK and PyRx were used for evaluating the binding affinities. The obtained results were further investigated for a post-dock analysis using Discovery Studio Visualizer 2016. The Desmond software package was used to conduct molecular dynamic simulations of best bound poses. Bergapten was further investigated for antidiarrheal, anti-secretory, charcoal meal transit time, anti-ulcer, anti-H. pylori activity.Results: Bergapten at a dose of 50, 100, and 200 mg/kg was proved effective in reducing diarrheal secretions, intestinal secretions, and distance moved by charcoal meal. Bergapten at the aforementioned doses acts as a gastroprotective agent in the ethanol-induced ulcer model that can be attributed to its effectiveness against H. pylori. Bergapten shows concentration-dependent relaxation of both spontaneous and K+ (80 mM)-induced contractions in the isolated rabbit jejunum model; the Ca2+ concentration–response curves (CRCs) were shifted to the right showing potentiating effect similar to papaverine. For molecular investigation, the H+/K+ ATPase inhibitory assay indicated inhibition of the pump comparable to omeprazole. Oxidative stress markers GST, GSH, and catalase showed increased expression, whereas the expression of LPO (lipid peroxidation) was reduced. Histopathological examination indicated marked improvement in cellular morphology. ELISA and western blot confirmed the reduction in inflammatory mediator expression. RT-PCR reduced the mRNA expression level of H+/K+ ATPase, confirming inhibition of the pump. The toxicological profile of bergapten was evaluated by an acute toxicity assay and evaluated for behavioral analysis, and the vital organs were used to analyze biochemical, hematological, and histopathological examination.Conclusion: Bergapten at the tested doses proved to be an antioxidant, anti-inflammatory, anti-ulcer, and antidiarrheal agent and relatively safe in acute toxicity assay.
- Published
- 2022
- Full Text
- View/download PDF
13. Mechanistic insights into the role of plant polyphenols and their nano-formulations in the management of depression
- Author
-
Atul Kabra, Ruchika Garg, James Brimson, Jelena Živković, Saud Almawash, Muhammad Ayaz, Asif Nawaz, Syed Shams Ul Hassan, and Simona Bungau
- Subjects
antidepressants ,polyphenols ,natural products ,depression ,herbal medicine ,Therapeutics. Pharmacology ,RM1-950 - Abstract
Depression is a condition characterized by low mood and an aversion to activity, that causes behavioral problems, poor quality of life and limits daily life activities. It is considered as the fourth leading cause of disability worldwide. Selective Serotonin Reuptake Inhibitors (SSRIs) Monoamine Oxidase (MAO) inhibitors, Tricyclic Antidepressants (TCAs), and atypical antidepressants are some of the conventional medications used to treat depression. However, only about half of patients with major depressive disorder (MDD) respond effectively to first-line antidepressant therapy. Additionally, there are a number of drawbacks to standard antidepressants, such as anti-cholinergic side effects, drug-drug interactions, and food-drug interactions, which prompts researchers to look at alternative approaches to the treatment of depression. Medicinal plants and their metabolites are extensively tested for their efficacy against depression. Electronic databases such as Google scholar, Science Direct, SciFinder and PubMed were used to search relevant literature on the role of polyphenols in depression. Plants-derived Polyphenols represent a major class of compounds extensively distributed in plants. Number of polyphenols have demonstrated antidepressant activity, among which berberine, piperine, curcumin, naringenin, ascorbic acid and ginsenosides are extensively evaluated. The medicinal plants and their derived compounds mediated synthesized green nanoparticles have also exhibited considerable efficacy in the management of depression. The therapeutic effects of these phytochemicals is mediated via differentiation and inhibition of neuronal cell apoptosis, promotion of neuronal cell survival and modulation of key neurotransmitters. The aim of this study is to review compressively the chemical, pharmacological and neurological evidence showing the potential of polyphenols in depression.
- Published
- 2022
- Full Text
- View/download PDF
14. Mild self-declared side effects of boosted darunavir associated with other antiretrovirals in Romanian HIV-1 infected patients
- Author
-
Ruxandra C. MARIN, Adrian STREINU-CERCEL, and Simona BUNGAU
- Subjects
antiretroviral therapy ,darunavir ,ritonavir ,cobicistat ,mild side reactions ,Medicine ,Medicine (General) ,R5-920 - Abstract
Introduction. Antiretroviral therapy (ART) is used in human immunodeficiency virus (HIV)-infected patients, to suppress viral replication and slow disease progression. The side effects of ART, milder or more serious, frequently occur, thus the main challenge for specialists is to find a balance between the benefits of long-term viremia suppression and the risks of toxicity. The objective of the study was to compare the frequency of mild side effects after administration of a regimen containing darunavir (DRV) boosted with ritonavir (RTV) (DRV/r 600 mg/100 mg, twice daily), vs DRV boosted with cobicistat (COBI) (DRV/c – 800 mg/150 mg, once a day) and perform a profile of the patient at risk of developing these types of adverse reactions during ARV treatment. Materials and methods. 462 patients were enrolled in the study and divided into two groups: 384 received DRV/r, and 78 DRV/c. This was a retrospective, non-interventional study using the database of the National Institute of Infectious Diseases “Prof. Dr. Matei Bals”, Bucharest, Romania. The self-declared mild side effects were collected from patients’ medical files and a comparison between the frequency of these in the two groups have been made. The main self-declared mild side effect was statistically correlated with the characteristic parameters of the cohort. Results. The statistical description of the most frequent self-declared mild side effects in the two groups showed that all parameters were found in a greater proportion in DRV/r group than in DRV/c group, with a statistically significant difference of p
- Published
- 2021
- Full Text
- View/download PDF
15. The neuroprotective effects of fisetin, a natural flavonoid in neurodegenerative diseases: Focus on the role of oxidative stress
- Author
-
Syed Shams ul Hassan, Saptadip Samanta, Raju Dash, Tomasz M. Karpiński, Emran Habibi, Abdul Sadiq, Amirhossein Ahmadi, and Simona Bungau
- Subjects
neurodegeneration ,flavonoid ,antioxidant ,fiestin ,oxidative stress ,Therapeutics. Pharmacology ,RM1-950 - Abstract
Oxidative stress (OS) disrupts the chemical integrity of macromolecules and increases the risk of neurodegenerative diseases. Fisetin is a flavonoid that exhibits potent antioxidant properties and protects the cells against OS. We have viewed the NCBI database, PubMed, Science Direct (Elsevier), Springer-Nature, ResearchGate, and Google Scholar databases to search and collect relevant articles during the preparation of this review. The search keywords are OS, neurodegenerative diseases, fisetin, etc. High level of ROS in the brain tissue decreases ATP levels, and mitochondrial membrane potential and induces lipid peroxidation, chronic inflammation, DNA damage, and apoptosis. The subsequent results are various neuronal diseases. Fisetin is a polyphenolic compound, commonly present in dietary ingredients. The antioxidant properties of this flavonoid diminish oxidative stress, ROS production, neurotoxicity, neuro-inflammation, and neurological disorders. Moreover, it maintains the redox profiles, and mitochondrial functions and inhibits NO production. At the molecular level, fisetin regulates the activity of PI3K/Akt, Nrf2, NF-κB, protein kinase C, and MAPK pathways to prevent OS, inflammatory response, and cytotoxicity. The antioxidant properties of fisetin protect the neural cells from inflammation and apoptotic degeneration. Thus, it can be used in the prevention of neurodegenerative disorders.
- Published
- 2022
- Full Text
- View/download PDF
16. Toxicity evaluation induced by single and 28-days repeated exposure of withametelin and daturaolone in Sprague Dawley rats
- Author
-
Muhammad Waleed Baig, Muhammad Majid, Bakht Nasir, Syed Shams ul Hassan, Simona Bungau, and Ihsan-ul Haq
- Subjects
withametelin ,daturaolone ,toxicity ,in vivo ,Datura ,Therapeutics. Pharmacology ,RM1-950 - Abstract
Safe preclinical dose determination is predictive of human toxicity and can have a profound impact on the overall progress of the compound in early drug discovery process. In this respect, current study sought to investigate for the first time the acute and subacute oral toxicity of two pharmacologically active natural compounds i.e., withametelin and daturaolone in Sprague Dawley rats following OECD guideline 420 and 407, respectively. As per acute toxicity studies, withametelin and daturaolone were characterized as Globally Harmonized System (GHS) category 4 and 5 compounds, respectively. Sub-acute daily dose of withametelin was 5, 2.5, and 1.25 mg/kg but, for daturaolone, it was 10, 5, and 2.5 mg/kg. High dose (5 and 2.5 mg/kg) withametelin groups showed dose dependent changes in the general, hematological, biochemical and histopathological parameters in both sexes, the most prominent being hyperthyroidism while no toxicity was observed at lower doses (1.25 and 0.75 mg/kg), No Observable Adverse Effect Level (NOAEL) being 1.25 mg/kg. Daturaolone was comparatively safer and showed dose dependent significant changes in hepatic enzyme (Alanine Transaminase), bilirubin, creatinine, and glucose levels while histological changes in testes were also observed. Lower doses (5, 2.5, and 1.25 mg/kg) of daturaolone showed no significant toxic effects and 5 mg/kg was declared as its NOAEL. Depending upon our findings, starting effective oral dose levels of 1.25 mg/kg/day for withametelin and 5 mg/kg/day for daturaolone are proposed for repeated dose (up to 28 days) preclinical pharmacological evaluation models. Long term studies with more behavioral, biochemical, histopathological and hormonal parameters are proposed to strengthen the findings.
- Published
- 2022
- Full Text
- View/download PDF
17. The road to precision medicine: Eliminating the 'One Size Fits All' approach in Alzheimer’s disease
- Author
-
Tapan Behl, Ishnoor Kaur, Aayush Sehgal, Sukhbir Singh, Ali Albarrati, Mohammed Albratty, Asim Najmi, Abdulkarim M. Meraya, and Simona Bungau
- Subjects
Alzheimer’s disease ,Precision medicine ,Personalized ,Neuroinflammatory ,Genetic ,Therapeutics. Pharmacology ,RM1-950 - Abstract
The expeditious advancement of Alzheimer’s Disease (AD) is a threat to the global healthcare system, that is further supplemented by therapeutic failure. The prevalence of this disorder has been expected to quadrupole by 2050, thereby exerting a tremendous economic pressure on medical sector, worldwide. Thus, there is a dire need of a change in conventional approaches and adopt a novel methodology of disease prevention, treatment and diagnosis. Precision medicine offers a personalized approach to disease management, It is dependent upon genetic, environmental and lifestyle factors associated with the individual, aiding to develop tailored therapeutics. Precision Medicine Initiatives are launched, worldwide, to facilitate the integration of personalized models and clinical medicine. The review aims to provide a comprehensive understanding of the neuroinflammatory processes causing AD, giving a brief overview of the disease interventions. This is further followed by the role of precision medicine in AD, constituting the genetic perspectives, operation of personalized form of medicine and optimization of clinical trials with the 3 R’s, showcasing an in-depth understanding of this novel approach in varying aspects of the healthcare industry, to provide an opportunity to the global AD researchers to elucidate suitable therapeutic regimens in clinically and pathologically complex diseases, like AD.
- Published
- 2022
- Full Text
- View/download PDF
18. Exploring protein tyrosine phosphatases (PTP) and PTP-1B inhibitors in management of diabetes mellitus
- Author
-
Tapan Behl, Amit Gupta, Aayush Sehgal, Ali Albarrati, Mohammed Albratty, Abdulkarim M. Meraya, Asim Najmi, Saurabh Bhatia, and Simona Bungau
- Subjects
Protein tyrosine phosphatase ,Diabetes mellitus ,Diabetic complications, PTP-1B inhibitors ,Therapeutics. Pharmacology ,RM1-950 - Abstract
Type 2 diabetes mellitus (T2D) is a metabolic disorder that knows no boundaries and is spread across the globe. It is one of the most widely spread metabolic disorder, which has now been described as a ‘lifestyle’ disease. According to the recent study conducted by International Diabetes Federation, the number of diabetic patients will rise from 463 million to 700 million by the year 2045. Conventional therapies often fail to define clear parameters and did not provide early detection in case of diabetes and pre-diabetes. Due to the limitations associated with these therapies, inclination of research is now focused on developing methods or exploring pathways which can overcome these hurdles. Considering these factors, protein tyrosine phosphatase is considered as a promising molecular level legitimate therapeutic target and is known to negatively regulate leptin and insulin signaling pathways. It has shown to be effective in the management of diabetes mellitus in various in vitro and in vivo studies. Various PTP-1B inhibitors have been studied which had shown promising results in the management of diabetes mellitus and associated complications as well. These inhibitors act by increasing insulin sensitivity by inhibiting PTP-1B mediated insulin pathway. In this article we will review the underlying mechanism of protein tyrosine phosphatase and its inhibitors by various PTP 1-B inhibitors for the management of diabetes mellitus and will further throw some light on the challenges and development of these inhibitors.
- Published
- 2022
- Full Text
- View/download PDF
19. Therapeutic insights elaborating the potential of retinoids in Alzheimer’s disease
- Author
-
Tapan Behl, Dapinder Kaur, Aayush Sehgal, Rajeev K. Singla, Hafiz A. Makeen, Mohammed Albratty, Hassan A. Alhazmi, Abdulkarim M. Meraya, and Simona Bungau
- Subjects
retinoids ,neuroinflammation ,RXRS ,RARS ,neurotransmission ,neuroplasticity ,Therapeutics. Pharmacology ,RM1-950 - Abstract
Alzheimer’s disease (AD) is perceived with various pathophysiological characteristics such oxidative stress, senile plaques, neuroinflammation, altered neurotransmission immunological changes, neurodegenerative pathways, and age-linked alterations. A great deal of studies even now are carried out for comprehensive understanding of pathological processes of AD, though many agents are in clinical trials for the treatment of AD. Retinoids and retinoic acid receptors (RARs) are pertinent to such attributes of the disease. Retinoids support the proper functioning of the immunological pathways, and are very potent immunomodulators. The nervous system relies heavily on retinoic acid signaling. The disruption of retinoid signaling relates to several pathogenic mechanisms in the normal brain. Retinoids play critical functions in the neuronal organization, differentiation, and axonal growth in the normal functioning of the brain. Disturbed retinoic acid signaling causes inflammatory responses, mitochondrial impairment, oxidative stress, and neurodegeneration, leading to Alzheimer’s disease (AD) progression. Retinoids interfere with the production and release of neuroinflammatory chemokines and cytokines which are located to be activated in the pathogenesis of AD. Also, stimulating nuclear retinoid receptors reduces amyloid aggregation, lowers neurodegeneration, and thus restricts Alzheimer’s disease progression in preclinical studies. We outlined the physiology of retinoids in this review, focusing on their possible neuroprotective actions, which will aid in elucidating the critical function of such receptors in AD pathogenesis.
- Published
- 2022
- Full Text
- View/download PDF
20. EFFECTS OF PROBIOTIC SUPPLEMENTATION ON METABOLIC SYNDROME COMPONENTS IN TYPE 2 DIABETES MELLITUS PATIENTS – A CASE-CONTROL STUDY
- Author
-
Raluca A. CORB ARON, Delia M. TIT, Anamaria L. PURZA, Areha ABID, Cosmin M. VESA, Gabriela ANGELESCU, and Simona BUNGAU
- Subjects
metabolic syndrome ,type 2 diabetes ,weight status ,glucidic profile ,lipidic profile. ,Medicine ,Medicine (General) ,R5-920 - Abstract
Introduction. Probiotics are well-known adjuvants, used as complementary therapeutic agents in health (e.g. metabolic or gastrointestinal) disorders, considering their beneficial role on gut microbiota, and their support in immunity. The objective of the study. This research followed the impact of probiotic supplementation on some clinical parameters related to metabolic syndrome (MS) and type 2 diabetes mellitus (T2DM) (weight status, body mass index, carbohydrate/ lipid profiles). Materials and methods. The comparative monitoring of the parameters was conducted over a 3- month period, on 41 subjects diagnosed with both MS and T2DM, who were separated into two groups, as follows: the study group (probiotics associated with allopathic treatment) and the control group (without probiotics). Results. Administration of dietary probiotics had a major impact on body weight, weight loss being significantly enhanced in the probiotic group than in the diet-only group (p=0.01). The effect of dietary probiotic administration on glucidic and lipidic profile was small (effect size (ES) 0.26 and 0.33, respectively), but better than in the control group, in whom the evolution was insignificant (ES 0.10 and 0.10, respectively). From a statistical point of view, the differences were insignificant (p>0.05). Conclusions. In the metabolic profile management of patients suffering from both MS and T2DM, probiotics administration had beneficial results, as highlighted by the results of the present study.
- Published
- 2021
- Full Text
- View/download PDF
21. Reviving the mutual impact of SARS-COV-2 and obesity on patients: From morbidity to mortality
- Author
-
Tapan Behl, Sachin Kumar, Sukhbir Singh, Saurabh Bhatia, Ali Albarrati, Mohammed Albratty, Abdulkarim M. Meraya, Asim Najmi, and Simona Bungau
- Subjects
Pandemic ,SARS-CoV-2 ,Obesity ,Respiratory compliance ,Inflammation ,Therapeutics. Pharmacology ,RM1-950 - Abstract
Obesity-related metabolic dysfunction, endothelium imbalance, chronic inflammation, immune dysregulation, and its comorbidities may all have a role in systemic inflammation, leading to the pulmonary fibrosis and cytokine storm, which leads to failure of lung function, which is a hallmark of severe SARS-CoV-2 infection. Obesity may also disrupt the function of mucociliary escalators and cooperation of epithelial cell’s motile cilia in the airway, limiting the clearance of the coronavirus that causes severe acute respiratory syndrome (SARS-CoV-2). Adipose tissues in obese patients have a greater number of proteases and receptors for SARS-CoV-2 admittance, proposing that they could serve as an accelerator and reservoir for this virus, boosting immunological response and systemic inflammation. Lastly, anti-inflammatory cytokines such as anti-IL-6 and the infusion of mesenchymal stem cells could be used as a modulation therapy of immunity to help COVID-19 patients. Obesity, on the other hand, is linked to the progress of COVID-19 through a variety of molecular pathways, and obese people are part of the SARS-CoV-2 susceptible individuals, necessitating more protective measures.
- Published
- 2022
- Full Text
- View/download PDF
22. The Locus Coeruleus – Noradrenaline system: Looking into Alzheimer’s therapeutics with rose coloured glasses
- Author
-
Tapan Behl, Ishnoor Kaur, Aayush Sehgal, Sukhbir Singh, Hafiz A. Makeen, Mohammed Albratty, Hassan A. Alhazmi, Saurabh Bhatia, and Simona Bungau
- Subjects
Alzheimer’s disease ,Neurotransmitters ,Noradrenaline ,Locus coeruleus ,Adrenergic system ,Therapeutics. Pharmacology ,RM1-950 - Abstract
Owing to the challenging ethos of global healthcare system, the Alzheimer’s Disease (AD) researchers are consistently striving for a suitable target for disease amelioration. Besides the neurotransmitter release by neurons, the cells release tau proteins and amyloid peptides, within the extracellular vacancies, aggregating into tangles and plaques (AD pathological hallmarks). During neuro-stimulation, release of neuromodulator noradrenaline (NA), contained in the locus coeruleus (LC), exerts a significant impact on the neurons and microglia. The production of amyloid-β (Aβ) and hyperphosphorylation of tau proteins are affected by the α2A and β adrenoreceptors, parallel to influencing their clearance. The manuscript entails a detailed understanding of the LC-NA system, as a possible avenue in AD management. The authors provide a comprehensive data on AD pathology and its link with LC neuroanatomical projections, followed by the pathogenic implications of LC-NA system in AD. The data also integrates numerous studies from online databases, evidently supporting the loss of the system integrity in AD patients, and the impact of the sympathetic system on specific AD hallmarks. Thus, the objective of this review is to compile a wide compendium of studies, for the convenience of the neuro-researchers, aiding in the establishment of a suitable therapeutic regimen for AD treatment.
- Published
- 2022
- Full Text
- View/download PDF
23. COVID-19 and diabetes: Association intensify risk factors for morbidity and mortality
- Author
-
Prateek Sharma, Tapan Behl, Neelam Sharma, Sukhbir Singh, Ajmer Singh Grewal, Ali Albarrati, Mohammed Albratty, Abdulkarim M. Meraya, and Simona Bungau
- Subjects
COVID-19 ,Diabetes mellitus ,SARS-CoV-2 ,Glucose homeostasis, Angiotensin-converting enzyme inhibitors ,Therapeutics. Pharmacology ,RM1-950 - Abstract
Diabetes is a condition that affects a large percentage of the population and it is the leading cause of a wide range of costly complications. Diabetes is linked to a multi-fold increase in mortality and when compared to non-diabetics, the intensity and prevalence of COVID-19 ailment among diabetic individuals are more. Since its discovery in Wuhan, COVID-19 has grown rapidly and shown a wide range of severity. Temperature, lymphopenia, non-productive cough, dyspnoea, and tiredness are recognized as the characteristic of individuals infected with COVID-19 disease. In COVID-19 patients, diabetes and other related comorbidities are substantial predictors of disease and mortality. According to a recent study, SARS-CoV-2 (the virus responsible for covid-19 disease) may also lead to direct pancreatic harm, which could aggravate hyperglycemia and potentially cause the establishment of diabetes in formerly non-diabetic individuals. This bidirectional association of COVID-19 and diabetes load the burden on health care professionals throughout the world. It is recommended that gliptin medications be taken moderately, blood glucose levels must be kept under control, ACE inhibitors should be used in moderation, decrease the number of avoidable hospitalizations, nutritional considerations, and some other prevention measures, such as immunization, are highly recommended. SARS-CoV-2 may cause pleiotropic changes in glucose homeostasis, which could exacerbate the pathophysiology of pre-existing diabetes or result in new disease processes.
- Published
- 2022
- Full Text
- View/download PDF
24. Biliary and Vascular Complications after Liver Transplantation–From Diagnosis to Treatment
- Author
-
Gina Gheorghe, Camelia Cristina Diaconu, Simona Bungau, Nicolae Bacalbasa, Natalia Motas, and Vlad-Alexandru Ionescu
- Subjects
liver transplantation ,biliary complications ,vascular complications ,graft dysfunction ,Medicine (General) ,R5-920 - Abstract
The last decades have brought impressive advances in liver transplantation. As a result, there was a notable rise in the number of liver transplants globally. Advances in surgical techniques, immunosuppressive therapies and radiologically guided treatments have led to an improvement in the prognosis of these patients. However, the risk of complications remains significant, and the management of liver transplant patients requires multidisciplinary teams. The most frequent and severe complications are biliary and vascular complications. Compared to vascular complications, biliary complications have higher incidence rates but a better prognosis. The early diagnosis and selection of the optimal treatment are crucial to avoid the loss of the graft and even the death of the patient. The development of minimally invasive techniques prevents surgical reinterventions with their associated risks. Liver retransplantation remains the last therapeutic solution for graft dysfunction, one of the main problems, in this case, being the low number of donors.
- Published
- 2023
- Full Text
- View/download PDF
25. Cross-talks among GBA mutations, glucocerebrosidase, and α-synuclein in GBA-associated Parkinson’s disease and their targeted therapeutic approaches: a comprehensive review
- Author
-
Tapan Behl, Gagandeep Kaur, Ovidiu Fratila, Camelia Buhas, Claudia Teodora Judea-Pusta, Nicoleta Negrut, Cristiana Bustea, and Simona Bungau
- Subjects
Parkinson’s disease ,Glycosylceramidase ,Glucocerebrosidase ,Gaucher’s disease ,Mutations ,α-Synuclein ,Neurology. Diseases of the nervous system ,RC346-429 - Abstract
Abstract Current therapies for Parkinson’s disease (PD) are palliative, of which the levodopa/carbidopa therapy remains the primary choice but is unable to modulate the progression of neurodegeneration. Due to the complication of such a multifactorial disorder and significant limitations of the therapy, numerous genetic approaches have been proved effective in finding out genes and mechanisms implicated in this disease. Following the observation of a higher frequency of PD in Gaucher’s disease (GD), a lysosomal storage condition, mutations of glycosylceramidase beta (GBA) encoding glucocerebrosidase (GCase) have been shown to be involved and have been explored in the context of PD. GBA mutations are the most common genetic risk factor of PD. Various studies have revealed the relationships between PD and GBA gene mutations, facilitating a better understanding of this disorder. Various hypotheses delineate that the pathological mutations of GBA minimize the enzymatic activity of GCase, which affects the proliferation and clearance of α-synuclein; this affects the lysosomal homeostasis, exacerbating the endoplasmic reticulum stress or encouraging the mitochondrial dysfunction. Identification of the pathological mechanisms underlying the GBA-associated parkinsonism (GBA + PD) advances our understanding of PD. This review based on current literature aims to elucidate various genetic and clinical characteristics correlated with GBA mutations and to identify the numerous pathological processes underlying GBA + PD. We also delineate the therapeutic strategies to interfere with the mutant GCase function for further improvement of the related α-synuclein–GCase crosstalks. Moreover, the various therapeutic approaches such as gene therapy, chaperone proteins, and histone deacetylase inhibitors for the treatment of GBA + PD are discussed.
- Published
- 2021
- Full Text
- View/download PDF
26. The influence of dietary interventions on paraclinical parameters in patients with metabolic syndrome
- Author
-
Timea C. GHITEA, Raluca A. CORB ARON, Liviu LAZAR, and Simona BUNGAU
- Subjects
homa index ,cholesterol ,triglycerides ,uric acid ,c-reactive protein ,metabolic syndrome ,Medicine ,Medicine (General) ,R5-920 - Abstract
Introduction. Patients with metabolic syndrome (MS) frequently present alterations of paraclinical tests. The effectiveness of dietary intervention has been intensively studied in the last decade. The objective of the study. This research studied the correlation of uric acid with the evolution of paraclinical parameters (HOMA index, cholesterol, triglycerides and C-reactive protein) in patients with MS, following the evolution of specific imbalances in MS, after an anti-inflammatory diet, associated or not with sport. Materials and methods. The monitoring of the parameters was performed over a period of 12 months, on a number of 110 patients, aged> 18 years, with HOMA index> 2, divided into three groups: control group, diet therapy group, and diet therapy and sports group, respectively. Results. Following the statistical processing, the correlation of the paraclinical parameters indicates the following: uric acid and cholesterol – Pearson coefficient r=0.192, p
- Published
- 2020
- Full Text
- View/download PDF
27. 'Aducanumab' making a comeback in Alzheimer’s disease: An old wine in a new bottle
- Author
-
Tapan Behl, Ishnoor Kaur, Aayush Sehgal, Sukhbir Singh, Neelam Sharma, Hafiz A. Makeen, Mohammed Albratty, Hassan A. Alhazmi, Shatha Ghazi Felemban, Amal M. Alsubayiel, Saurabh Bhatia, and Simona Bungau
- Subjects
Amyloid ,Alzheimer’s Disease ,Antibody ,Aducanumab ,Controversy ,Therapeutics. Pharmacology ,RM1-950 - Abstract
Despite presence of substantial evidence suggesting the pivotal role of amyloid (Aβ) in Alzheimer's disease (AD), very few therapeutic agents have been able to ameliorate the disease. This paved the way for the discovery of antibody-based immunotherapy to ace Aβ clearance and curb neuronal toxicity, resulting in revival of aducanumab, which following its entry into the brain, interacts with the parenchymal amyloid and decreases Aβ concentration, in a dose-dependent manner. However, the surprising approval from the FDA has created a controversy among healthcare professionals, due to Alzheimer's related imaging abnormality (ARIA) and hypersensitivity, serving as backlogs in its acceptance. Therefore, aducanumab is recognised as being “risen from the grave”, accompanied with contrasting statements within the healthcare paradigm. The manuscript provides a collection of data, aiming to elucidate, both the commendable and critical faces, simultaneously intending to gain the attention of the global researchers towards the possibility of disease-modifying therapy in AD. The manuscript discusses the failure of anti-amyloid therapies in AD, that have accelerated the need to find a suitable therapeutic approach, followed by the discussion of timeline and impact of aducanumab in AD models, alongside the controversial judgement raising significant question. Besides, the authors throw some light on the onco-therapeutic implications of the drug approval, which is identified as a significant consequence of the event. The text provides a holistic picture of the drug action, and enlists the considerations for the future, that might be beneficial to both the acceptance of the drug, and the treatment of the disease.
- Published
- 2022
- Full Text
- View/download PDF
28. There is nothing exempt from the peril of mutation – The Omicron spike
- Author
-
Tapan Behl, Ishnoor Kaur, Aayush Sehgal, Sukhbir Singh, Neelam Sharma, Md Khalid Anwer, Hafiz A. Makeen, Mohammed Albratty, Hassan A. Alhazmi, Saurabh Bhatia, and Simona Bungau
- Subjects
Corona virus ,Omicron ,Variant of concern ,Receptor binding domain ,Spike ,ACE2 ,Therapeutics. Pharmacology ,RM1-950 - Abstract
The 2019 corona virus disease (COVID-19) has caused a global chaos, where a novel Omicron variant has challenged the healthcare system, followed by which it has been referred to as a variant of concern (VOC) by the World Health Organization (WHO), owing to its alarming transmission and infectivity rate. The large number of mutations in the receptor binding domain (RBD) of the spike protein is responsible for strengthening of the spike-angiotensin-converting enzyme 2 (ACE2) interaction, thereby explaining the elevated threat. This is supplemented by enhanced resistance of the variant towards pre-existing antibodies approved for the COVID-19 therapy. The manuscript brings into light failure of existing therapies to provide the desired effect, however simultaneously discussing the novel possibilities on the verge of establishing suitable treatment portfolio. The authors entail the risks associated with omicron resistance against antibodies and vaccine ineffectiveness on one side, and novel approaches and targets – kinase inhibitors, viral protease inhibitors, phytoconstituents, entry pathways – on the other. The manuscript aims to provide a holistic picture about the Omicron variant, by providing comprehensive discussions related to multiple aspects of the mutated spike variant, which might aid the global researchers and healthcare experts in finding an optimised solution to this pandemic.
- Published
- 2022
- Full Text
- View/download PDF
29. Exploring the potential role of rab5 protein in endo-lysosomal impairment in Alzheimer’s disease
- Author
-
Tapan Behl, Dapinder Kaur, Aayush Sehgal, Sukhbir Singh, Hafiz A. Makeen, Mohammed Albratty, Ahmed A.H. Abdellatif, Sudharshan Reddy Dachani, and Simona Bungau
- Subjects
Alzheimer’s Disease ,Endo-lysosomal ,Rab5 Protein ,Neurology ,Therapeutics. Pharmacology ,RM1-950 - Abstract
Growing evidence suggests that neuronal dysfunction in the endo-lysosomal and autophagic processes contributes to the onset and progression of neurodegenerative diseases such as Alzheimer's disease (AD). Since they are the primary cellular systems involved in the production and clearance of aggregated amyloid plaques, endo-lysosomal or autophagic equilibrium must be maintained throughout life. As a result, variations in the autophagic and endo-lysosomal torrent, as a measure of degenerative function in these sections or pathways, may have a direct impact on disease-related processes, such as Aß clearance from the brain and interneuronal deposition of Aß and tau aggregates, thus disrupting synaptic plasticity. The discovery of several chromosomal factors for Alzheimer's disease that are clinically linked to regulation of the endocytic pathway, including protein aggregation and removal, supports the theory that the endo-lysosomal/autophagic torrent is more susceptible to impairment, especially as people age, thus catalysing the onset of disease. Although the role of endo-lysosomal/autophagic dysfunction in neurodegeneration has progressed in recent years, the field remains underdeveloped. Because of its possible therapeutic implications in Alzheimer's disease, further study is needed to explain the possibilities for effective autophagy regulation.
- Published
- 2022
- Full Text
- View/download PDF
30. Involvement of molecular chaperone in protein-misfolding brain diseases
- Author
-
Nitu L. Wankhede, Mayur B. Kale, Aman B. Upaganlawar, Brijesh G. Taksande, Milind J. Umekar, Tapan Behl, Ahmed A.H. Abdellatif, Prasanna Mohana Bhaskaran, Sudarshan Reddy Dachani, Aayush Sehgal, Sukhbir Singh, Neelam Sharma, Hafiz A. Makeen, Mohammed Albratty, Hamed Ghaleb Dailah, Saurabh Bhatia, Ahmed Al-Harrasi, and Simona Bungau
- Subjects
Protein misfolding and aggregation ,Molecular chaperone ,Alzheimer’s disease (AD) ,Parkinson’s disease (PD) ,Amyotrophic lateral sclerosis (ALS) ,Huntington’s disease (HD) ,Therapeutics. Pharmacology ,RM1-950 - Abstract
Protein misfolding causes aggregation and build-up in a variety of brain diseases. There are numeral molecules that are linked with the protein homeostasis mechanism. Molecular chaperones are one of such molecules that are responsible for protection against protein misfolded and aggregation-induced neurotoxicity. Many studies have explored the participation of molecular chaperones in Parkinson’s disease, Alzheimer’s disease, Amyotrophic lateral sclerosis, and Huntington’s diseases. In this review, we highlighted the constructive role of molecular chaperones in neurological diseases characterized by protein misfolding and aggregation and their capability to control aberrant protein interactions at an early stage thus successfully suppressing pathogenic cascades. A comprehensive understanding of the protein misfolding associated with brain diseases and the molecular basis of involvement of chaperone against aggregation-induced cellular stress might lead to the progress of new therapeutic intrusion-related to protein misfolding and aggregation.
- Published
- 2022
- Full Text
- View/download PDF
31. Polyphenols inhibiting MAPK signalling pathway mediated oxidative stress and inflammation in depression
- Author
-
Tapan Behl, Tarapati Rana, Ghallab H. Alotaibi, Md. Shamsuzzaman, Maaz Naqvi, Aayush Sehgal, Sukhbir Singh, Neelam Sharma, Yosif Almoshari, Ahmed A.H. Abdellatif, Muhammad Shahid Iqbal, Saurabh Bhatia, Ahmed Al-Harrasi, and Simona Bungau
- Subjects
Oxidative stress ,Depression ,Antidepressants ,Inflammation ,Psychiatric disorders ,Therapeutics. Pharmacology ,RM1-950 - Abstract
Depression is one of the most debilitating psychiatric disorders affecting people of all ages worldwide. Despite significant heterogeneity between studies, increased inflammation and oxidative stress have been found in depression. Oxidative stress and inflammation are involved in the pathogenesis of depression. In the current review, we discussed the markers of oxidative stress and inflammation in depressive disorder and the association between these markers and the antidepressant treatment. The role of natural polyphenols in regulating various cell signaling pathways related to oxidative stress and inflammation has also been reviewed. The inhibitory effect of polyphenols on several cell signaling pathways reveals the vital role of polyphenols in the prevention and treatment of depressive disorder. Understanding the mechanism of polyphenols implicated in the regulation of cell signaling pathways is essential for the identification of lead compounds and the development of novel effective compounds for the prevention and treatment of depressive disorder.
- Published
- 2022
- Full Text
- View/download PDF
32. Interrelationships between hyperuricemia, metabolic syndrome and chronic kidney disease in patients with diabetes mellitus
- Author
-
Adriana BAIDOG, Simona BUNGAU, Tapan BEHL, Ioana RATIU, Raluca A. CORB ARON, Francesca URSU, Liviu LAZAR, and Cosmin M. VESA
- Subjects
hyperuricemia ,metabolic syndrome ,type 2 diabetes mellitus ,chronic kidney disease ,Medicine ,Medicine (General) ,R5-920 - Abstract
Introduction. Hyperuricemia is a strong predictor of an altered metabolic status. There are complex interrelationships between hyperuricemia, type 2 diabetes mellitus (T2DM), metabolic syndrome (MS) and chronic kidney disease (CKD). The objective of the study was to investigate the impact of hyperuricemia on the prevalence of MS and glomerular function in patients with T2DM. Materials and methods. This retrospective study included 300 patients with T2DM, hospitalized for one day in the diabetes clinic, between 01.01.2016-31.12.2018; all the data used for the analysis were obtained from the medical records. Results. The prevalence of hyperuricemia was 46%. MS was identified in 88.41% patients with hyperuricemia compared to 61.73% in patients with normo-uricemia (p
- Published
- 2020
- Full Text
- View/download PDF
33. Underactive bladder - an underestimated entity
- Author
-
Spinu Arsenie Dan, Ovidiu Gabriel Bratu, Dragos Radu Marcu, Adina Elena Stanciu, Florentina Gherghiceanu, Florentina Ionita-Radu, Simona Bungau, Ana Maria Alexandra Stanescu, and Dan Mischianu
- Subjects
underactive bladder ,detrusor underactivity ,diagnosis ,treatment ,Medicine (General) ,R5-920 - Abstract
Introduction. The concept of underactive bladder is relatively new. Currently there is no generally accepted definition of this pathology. Diagnosis depends on urodynamic findings, and symptoms are usually rare and intricated with the symptoms of other urinary pathology. Matherials and methods. This review examines the current literature on underactive bladder regarding pathology, definition, diagnosis, current guidelines, and any further potential medical developments. Conclusions. Underactive bladder is a poorly understood pathologic condition. Only since 2002 has there been any consensus regarding the definition. The diagnosis relies only on urodynamics; clinical diagnosis is a challenge even for a consultant; and treatment does not seem to alleviate much of the suffering. This disease remains underrecognized and undertreated. More research is needed to identify less invasive diagnosis tools and treatment for this pathology.
- Published
- 2020
- Full Text
- View/download PDF
34. In-Silico Lead Druggable Compounds Identification against SARS COVID-19 Main Protease Target from In-House, Chembridge and Zinc Databases by Structure-Based Virtual Screening, Molecular Docking and Molecular Dynamics Simulations
- Author
-
Mehreen Ghufran, Mehran Ullah, Haider Ali Khan, Sabreen Ghufran, Muhammad Ayaz, Muhammad Siddiq, Syed Qamar Abbas, Syed Shams ul Hassan, and Simona Bungau
- Subjects
main protease (Mpro) ,structure-based virtual screening ,ZINC ,in-house ,ChemBridge database ,molecular dynamics simulation ,Technology ,Biology (General) ,QH301-705.5 - Abstract
Pharmacological strategies to lower the viral load among patients suffering from severe diseases were researched in great detail during the SARS-CoV-2 outbreak. The viral protease Mpro (3CLpro) is necessary for viral replication and is among the main therapeutic targets proposed, thus far. To stop the pandemic from spreading, researchers are working to find more effective Mpro inhibitors against SARS-CoV-2. The 33.8 kDa Mpro protease of SARS-CoV-2, being a nonhuman homologue, has the possibility of being utilized as a therapeutic target against coronaviruses. To develop drug-like compounds capable of preventing the replication of SARS-main CoV-2’s protease (Mpro), a computer-aided drug design (CADD) approach is extremely viable. Using MOE, structure-based virtual screening (SBVS) of in-house and commercial databases was carried out using SARS-CoV-2 proteins. The most promising hits obtained during virtual screening (VS) were put through molecular docking with the help of MOE. The virtual screening yielded 3/5 hits (in-house database) and 56/66 hits (commercial databases). Finally, 3/5 hits (in-house database), 3/5 hits (ZINC database), and 2/7 hits (ChemBridge database) were chosen as potent lead compounds using various scaffolds due to their considerable binding affinity with Mpro protein. The outcomes of SBVS were then validated using an analysis based on molecular dynamics simulation (MDS). The complexes’ stability was tested using MDS and post-MDS. The most promising candidates were found to exhibit a high capacity for fitting into the protein-binding pocket and interacting with the catalytic dyad. At least one of the scaffolds selected will possibly prove useful for future research. However, further scientific confirmation in the form of preclinical and clinical research is required before implementation.
- Published
- 2023
- Full Text
- View/download PDF
35. Extragonadal germ-cell tumors – a review of the pathogenesis, histopathological findings, diagnosis and treatment
- Author
-
Lucian IORGA, Dragos MARCU, Ovidiu BRATU, Bogdan SOCEA, Tiberiu P. NEAGU, Simona BUNGAU, Ana Maria A. STANESCU, Camelia C. DIACONU, and Dan MISCHIANU
- Subjects
extragonadal germ-cell tumors ,pathogenesis ,histhopathology ,diagnosis ,treatment ,Medicine ,Medicine (General) ,R5-920 - Abstract
Primary extragonadal germ-cell tumors (EGCTs) are a rare group of neoplasms, that can exist anywere along the midline of the body, without the evidence of a primary gonadal tumor. Their morphology varies widely and includes teratoma, seminoma, yolk sac tumor, embryonal carcinoma, choriocarcinoma, and mixed GCTs. The ethiopathogenesis of EGCT is poorly understood, existing multiple theories. Diagnosis is often difficult, but an accurate one should be made in order to apply a correct management.
- Published
- 2019
- Full Text
- View/download PDF
36. Interweaving epilepsy and neurodegeneration: Vitamin E as a treatment approach
- Author
-
Aman B. Upaganlawar, Nitu L. Wankhede, Mayur B. Kale, Mohit D. Umare, Aayush Sehgal, Sukhbir Singh, Saurabh Bhatia, Ahmed Al-Harrasi, Agnieszka Najda, Renata Nurzyńska-Wierdak, Simona Bungau, and Tapan Behl
- Subjects
Epilepsy ,Neurodegeneration ,Oxidative stress ,Excitotoxicity ,Neuroinflammation ,Vitamin E ,Therapeutics. Pharmacology ,RM1-950 - Abstract
Epilepsy is the most common neurological disorder, affecting nearly 50 million people worldwide. The condition can be manifested either due to genetic predisposition or acquired from acute insult which leads to alteration of cellular and molecular mechanisms. Evaluating the latest and the current knowledge in regard to the mechanisms underlying molecular and cellular alteration, hyperexcitability is a consequence of an imbalanced state wherein enhance excitatory glutamatergic and reduced inhibitory GABAergic signaling is considered to be accountable for seizures associated damage. However, neurodegeneration contributing to epileptogenesis has become increasingly appreciated. The components at the helm of neurodegenerative alterations during epileptogenesis include GABAergic neuronal and receptor changes, neuroinflammation, alteration in axonal transport, oxidative stress, excitotoxicity, and other cellular as well as functional changes. Targeting neurodegeneration with vitamin E as an antioxidant, anti-inflammatory and neuroprotective may prove to be one of the therapeutic approaches useful in managing epilepsy. In this review, we discuss and converse about the seizure-induced episodes as a link for the development of neurodegenerative and pathological consequences of epilepsy. We also put forth a summary of the potential intervention with vitamin E therapy in the management of epilepsy.
- Published
- 2021
- Full Text
- View/download PDF
37. Applications of Extracellular Vesicles in Nervous System Disorders: An Overview of Recent Advances
- Author
-
Safir Ullah Khan, Muhammad Imran Khan, Munir Ullah Khan, Noor Muhammad Khan, Simona Bungau, and Syed Shams ul Hassan
- Subjects
exosomes ,central nervous system diseases ,engineering modification ,vehicles ,bioengineering ,Technology ,Biology (General) ,QH301-705.5 - Abstract
Diseases affecting the brain and spinal cord fall under the umbrella term “central nervous system disease”. Most medications used to treat or prevent chronic diseases of the central nervous system cannot cross the blood–brain barrier (BBB) and hence cannot reach their intended target. Exosomes facilitate cellular material movement and signal transmission. Exosomes can pass the blood–brain barrier because of their tiny size, high delivery efficiency, minimal immunogenicity, and good biocompatibility. They enter brain endothelial cells via normal endocytosis and reverse endocytosis. Exosome bioengineering may be a method to produce consistent and repeatable isolation for clinical usage. Because of their tiny size, stable composition, non-immunogenicity, non-toxicity, and capacity to carry a wide range of substances, exosomes are indispensable transporters for targeted drug administration. Bioengineering has the potential to improve these aspects of exosomes significantly. Future research into exosome vectors must focus on redesigning the membrane to produce vesicles with targeting abilities to increase exosome targeting. To better understand exosomes and their potential as therapeutic vectors for central nervous system diseases, this article explores their basic biological properties, engineering modifications, and promising applications.
- Published
- 2022
- Full Text
- View/download PDF
38. Ameliorative Effect of Structurally Divergent Oleanane Triterpenoid, 3-Epifriedelinol from Ipomoea batatas against BPA-Induced Gonadotoxicity by Targeting PARP and NF-κB Signaling in Rats
- Author
-
Muhammad Majid, Anam Farhan, Muhammad Waleed Baig, Muhammad Tariq Khan, Yousaf Kamal, Syed Shams ul Hassan, Simona Bungau, and Ihsan-ul Haq
- Subjects
Ipomoea ,aerial part ,sweet potato ,inflammation ,prostate ,antiproliferative ,Organic chemistry ,QD241-441 - Abstract
The pentacyclic triterpenoids (PTs) of plant origin are reputed to restrain prostate cancer (PCa) cell proliferation. This study aims to assess 3-epifriedelinol (EFD) isolated from aerial part of Ipomoea batatas against PCa and its potential mechanism, in vitro and in vivo. Molecular docking affirms good binding affinity of the compound with target proteins exhibiting binding energy of −7.9 Kcal/mol with BAX, −8.1 Kcal/mol (BCL-2), −1.9 Kcal/mol (NF-κB) and −8.5 Kcal/mol with P53. In the MTT assay, EFD treatment (3–50 µM) showed a significant (p < 0.05 and p < 0.01) dose and time dependent drop in the proliferative graph of DU145 and PC3, and an upsurge in apoptotic cell population. EFD displayed substantial IC50 against DU145 (32.32 ± 3.72 µM) and PC3 (35.22 ± 3.47 µM). According to Western blots, EFD administration significantly enhanced the cleavage of caspases and PARP, elevated BAX and P53 and decreased BCL-2 and NF-κB expression, thereby triggering apoptosis in PCa cells. When male Sprague Dawley rats were intoxicated with Bisphenol A (BPA), an apparent increase in prostate mass (0.478 ± 0.08 g) in comparison to control (0.385 ± 0.03 g) indicates prostatitis. Multidose treatment of EFD (10 mg/kg) significantly reduced prostate size (0.404 ± 0.05 g). EFD exhibited substantial curative potential in vivo, as hematological, hormonal and histopathological parameters have been significantly improved. Reduced peroxidation (TBARS), and suppression of inflammatory markers i.e., NO, IL-6 and TNF-α, signposts substantial antiinflammatory potential of the compound. Overall, EFD has shown better binding affinity with target molecules, acceptable ADMET profile, potent antiproliferative and apoptotic nature and significant reduction in inflamed prostate mass of rats. The present study demonstrates acceptable physicochemical and pharmacokinetic properties of the compound with excellent drugable nature, hence EFD in the form of standardized formulation can be developed as primary or adjuvant therapy against PCa and toxins-induced gonadotoxicity.
- Published
- 2022
- Full Text
- View/download PDF
39. Integrated Bioinformatics-Based Subtractive Genomics Approach to Decipher the Therapeutic Drug Target and Its Possible Intervention against Brucellosis
- Author
-
Kanwal Khan, Munirah Sulaiman Othman Alhar, Muhammad Naseer Abbas, Syed Qamar Abbas, Mohsin Kazi, Saeed Ahmad Khan, Abdul Sadiq, Syed Shams ul Hassan, Simona Bungau, and Khurshid Jalal
- Subjects
isocitrate lyase ,Brucella suis ,molecular docking ,brucellosis ,Technology ,Biology (General) ,QH301-705.5 - Abstract
Brucella suis, one of the causative agents of brucellosis, is Gram-negative intracellular bacteria that may be found all over the globe and it is a significant facultative zoonotic pathogen found in livestock. It may adapt to a phagocytic environment, reproduce, and develop resistance to harmful environments inside host cells, which is a crucial part of the Brucella life cycle making it a worldwide menace. The molecular underpinnings of Brucella pathogenicity have been substantially elucidated due to comprehensive methods such as proteomics. Therefore, we aim to explore the complete Brucella suis proteome to prioritize the novel proteins as drug targets via subtractive proteo-genomics analysis, an effort to conjecture the existence of distinct pathways in the development of brucellosis. Consequently, 38 unique metabolic pathways having 503 proteins were observed while among these 503 proteins, the non-homologs (n = 421), essential (n = 350), drug-like (n = 114), virulence (n = 45), resistance (n = 42), and unique to pathogen proteins were retrieved from Brucella suis. The applied subsequent hierarchical shortlisting resulted in a protein, i.e., isocitrate lyase, that may act as potential drug target, which was finalized after the extensive literature survey. The interacting partners for these shortlisted drug targets were identified through the STRING database. Moreover, structure-based studies were also performed on isocitrate lyase to further analyze its function. For that purpose, ~18,000 ZINC compounds were screened to identify new potent drug candidates against isocitrate lyase for brucellosis. It resulted in the shortlisting of six compounds, i.e., ZINC95543764, ZINC02688148, ZINC20115475, ZINC04232055, ZINC04231816, and ZINC04259566 that potentially inhibit isocitrate lyase. However, the ADMET profiling showed that all compounds fulfill ADMET properties except for ZINC20115475 showing positive Ames activity; whereas, ZINC02688148, ZINC04259566, ZINC04232055, and ZINC04231816 showed hepatoxicity while all compounds were observed to have no skin sensitization. In light of these parameters, we recommend ZINC95543764 compound for further experimental studies. According to the present research, which uses subtractive genomics, proteins that might serve as therapeutic targets and potential lead options for eradicating brucellosis have been narrowed down.
- Published
- 2022
- Full Text
- View/download PDF
40. Unveiling the role of polyphenols in diabetic retinopathy
- Author
-
Tapan Behl, Keshav Kumar, Sukhbir Singh, Aayush Sehgal, Monika Sachdeva, Saurabh Bhatia, Ahmed Al-Harrasi, Camelia Buhas, Claudia Teodora Judea-Pusta, Nicoleta Negrut, Mihai Alexandru Munteanu, Ciprian Brisc, and Simona Bungau
- Subjects
Polyphenols ,Phytochemicals ,Diabetic retinopathy ,Vascular endothelial growth factor ,Antioxidant ,Anti-inflammatory ,Nutrition. Foods and food supply ,TX341-641 - Abstract
Diabetes retinopathy (DR) is the leading cause of blindness and is considered as the most ordinary microvascular complication of diabetes mellitus (DM). The current available therapies can only be effective in the progressive stages of DR and there are various clinical studies which depicts the inconclusive outcomes of these available therapies after assessing the long-term efficacy and safety of such treatments. Moreover, there is an indispensable need of a more reliable as well as potent treatment which can be considered as more efficacious treatment for the management of DR. The treatment of DR can be possible at the early stages with polyphenols which are plant derived chemical agents and can be act as an alternative to other treatments and can optimistically prevent the further evolution of disease. The present review emphasizes the role of polyphenols on cellular and molecular mechanisms altered by DR in preclinical and clinical studies.
- Published
- 2021
- Full Text
- View/download PDF
41. Rice bran, an off-shoot to newer therapeutics in neurological disorders
- Author
-
Tapan Behl, Sachin Kumar, Aayush Sehgal, Sukhbir Singh, Shilpa Kumari, Mihaela Cristina Brisc, Mihai Alexandru Munteanu, Ciprian Brisc, Camelia Liana Buhas, Claudia Judea-Pusta, Delia Carmen Nistor-Cseppento, and Simona Bungau
- Subjects
Neurodegeneration ,Rice bran ,Nutritional intake ,Natural anti-oxidant ,Anti-inflammation ,γ-oryzanol ,Therapeutics. Pharmacology ,RM1-950 - Abstract
Normal brain functioning involves the interaction of interconnected molecular and cellular activities, which appear to alter normal to abnormal brain functioning when worsened, contributing to the emergence of neurological disorders. There are currently millions of people who are living with brain disorders globally and this will rise if suitable prevention strategies are not explored. Nutraceutical intended to treat numerous health goals with little adverse effect possible together can be more beneficial than pharmaceutical monotherapy for fostering balanced brain functioning. Nutraceutical provides a specific composition of effective macronutrients and micronutrients that are difficult to synthesize in the laboratory. Numerous elements of rice fibers in rice bran are characterized as natural anti-oxidant and having potential anti-inflammatory activity. The rice bran captures interest among the researchers as it is widespread, affordable, and rich in nutrients including protein, fat, carbohydrates, bioactive components, and dietary fiber. This review covers the neuroprotective multiplicity of rice bran and its constituents to deter pathological conditions of the brain and to facilitate balanced brain functioning at the same time.
- Published
- 2021
- Full Text
- View/download PDF
42. Melatonin Pretreatment Alleviated Inhibitory Effects of Drought Stress by Enhancing Anti-Oxidant Activities and Accumulation of Higher Proline and Plant Pigments and Improving Maize Productivity
- Author
-
Nasib Gul, Zia Ul Haq, Hina Ali, Fazal Munsif, Syed Shams ul Hassan, and Simona Bungau
- Subjects
melatonin concentration ,relative water content ,chlorophyll content ,mild drought stress ,Agriculture - Abstract
Drought stress has been shown to have harmful effects on crop productivity worldwide, including in Pakistan, due to rapid climate change scenarios. Extensive work has been reported on the influential role of melatonin (MEL) in either foliar or seed-primed applications; however, its role in root application is seldom reported. We investigated plant biochemical responses, including anti-oxidants, plant pigments, leaf water characteristics, and maize crop production, with MEL treatment under mild and severe drought stress. Maize Cvar. Jalal was subjected to drought stress (60% and 80% of full irrigation) at the four-leaf stage, and MEL was applied as pretreatment with irrigation water at different doses (0, 100, and 200µM). The findings of the study revealed that the Chl a, b, and a + b contents and the carotenoid content significantly increased with MEL application during severe and mild drought stress. After applying 200 µM MEL, leaf water attributes, comprising relative water content (RWC), leaf water content (LWC), and relative saturation deficit (RSD), increased by 1.9%, 100%, and 71.2%, respectively, during mild drought and 17%, 133%, and 32% under severe drought. The anti-oxidant activities of POD, CAT, and APX were remarkably enhanced with MEL during drought stress. Our results showed that root application of 200 µM melatonin boosted seed yield and water productivity by 31% and 38%, and plant biomass increased by 32% and 29% under mild and severe drought stressors compared to plants with no MEL, leading to increased drought tolerance.
- Published
- 2022
- Full Text
- View/download PDF
43. Alzheimer’s Disease as a Major Public Health Concern: Role of Dietary Saponins in Mitigating Neurodegenerative Disorders and Their Underlying Mechanisms
- Author
-
Asaad A. Abduljawad, Mohammed Ahmed Elawad, Modawy Elnour Modawy Elkhalifa, Alshebli Ahmed, Alashary Adam Eisa Hamdoon, Liga Hasan Mohammed Salim, Muhammad Ashraf, Muhammad Ayaz, Syed Shams ul Hassan, and Simona Bungau
- Subjects
saponins ,neurodegenerative disorders ,Alzheimer’s disease ,signaling pathways ,neurotrophins ,Organic chemistry ,QD241-441 - Abstract
Saponins are triterpenoid or steroidal glycosides and are an important group of naturally occurring compounds of plant origin. They exhibit diverse pharmacological potentials including radical scavenging, as well as neuroprotective, anti-diabetic and anti-inflammatory activities, owing to their diverse chemical scaffolds. Saponins consist of an aglycone part (non-sugar) and a glycone part (sugar) and have at least one glycosidic (C–O sugar bond) linkage present between the glycone and aglycone mostly at C-3. On the basis of the aglycone part, saponins are classified into triterpenoid glycosides, steroid glycosides and alkaloid glycosides. Saponins exhibit neuroprotective activities against various disorders of the central nervous system (CNS) including stroke, Alzheimer’s disease (AD), Huntington’s disease (HD) and Parkinson’s disease (PD). They mediate their therapeutic effects by modulation of various pathological targets. This study highlights various neuroprotective mechanisms of saponins including free radical scavenging, modulation of neuroprotective signaling pathways, activation of neurotrophic factors, modulation of neurotransmitters, inhibition of BACE1 enzyme and tau hyper-phosphorylation. The study concludes that saponins have considerable efficacy against various pathological targets of neurological disorders, especially AD, and might be an important source of leads against neurodegenerative disorders.
- Published
- 2022
- Full Text
- View/download PDF
44. Fluorescent and Phosphorescent Nitrogen-Containing Heterocycles and Crown Ethers: Biological and Pharmaceutical Applications
- Author
-
Faiz Ullah, Sami Ullah, Muhammad Farhan Ali Khan, Muhammad Mustaqeem, Rizwan Nasir Paracha, Muhammad Fayyaz ur Rehman, Fariha Kanwal, Syed Shams ul Hassan, and Simona Bungau
- Subjects
fluorescence ,heterocyclic compounds ,antitumor ,antifungal ,anti-microbial ,Organic chemistry ,QD241-441 - Abstract
Fluorescent molecules absorb photons of specific wavelengths and emit a longer wavelength photon within nanoseconds. Recently, fluorescent materials have been widely used in the life and material sciences. Fluorescently labelled heterocyclic compounds are useful in bioanalytical applications, including in vivo imaging, high throughput screening, diagnostics, and light-emitting diodes. These compounds have various therapeutic properties, including antifungal, antitumor, antimalarial, anti-inflammatory, and analgesic activities. Different neutral fluorescent markers containing nitrogen heterocycles (quinolones, azafluoranthenes, pyrazoloquinolines, etc.) have several electrochemical, biological, and nonlinear optic applications. Photodynamic therapy (PDT), which destroys tumors and keeps normal tissues safe, works in the presence of molecular oxygen with light and a photosensitizing drugs (dye) to obtain a therapeutic effect. These compounds can potentially be effective templates for producing devices used in biological research. Blending crown compounds with fluorescent residues to create sensors has been frequently investigated. Florescent heterocyclic compounds (crown ether) increase metal solubility in non-aqueous fluids, broadening the application window. Fluorescent supramolecular polymers have widespread use in fluorescent materials, fluorescence probing, data storage, bio-imaging, drug administration, reproduction, biocatalysis, and cancer treatment. The employment of fluorophores, including organic chromophores and crown ethers, which have high selectivity, sensitivity, and stability constants, opens up new avenues for research. Fluorescent organic compounds are gaining importance in the biological world daily because of their diverse functionality with remarkable structural features and positive properties in the fields of medicine, photochemistry, and spectroscopy.
- Published
- 2022
- Full Text
- View/download PDF
45. Exfoliation of MoS2 Quantum Dots: Recent Progress and Challenges
- Author
-
Luqman Ali, Fazle Subhan, Muhammad Ayaz, Syed Shams ul Hassan, Clare Chisu Byeon, Jong Su Kim, and Simona Bungau
- Subjects
2D materials ,graphene ,MoS2 ,quantum dots ,exfoliation ,Chemistry ,QD1-999 - Abstract
Although, quantum dots (QDs) of two-dimensional (2D) molybdenum disulfide (MoS2) have shown great potential for various applications, such as sensing, catalysis, energy storage, and electronics. However, the lack of a simple, scalable, and inexpensive fabrication method for QDs is still a challenge. To overcome this challenge, a lot of attention has been given to the fabrication of QDs, and several fabrication strategies have been established. These exfoliation processes are mainly divided into two categories, the ‘top-down’ and ‘bottom-up’ methods. In this review, we have discussed different top-down exfoliation methods used for the fabrication of MoS2 QDs and the advantages and limitations of these methods. A detailed description of the various properties of QDs is also presented.
- Published
- 2022
- Full Text
- View/download PDF
46. Pharmacological Basis of Rumex hastatus D. Don in Gastrointestinal Diseases with Focusing Effects on H+/K+-ATPase, Calcium Channels Inhibition and PDE Mediated Signaling: Toxicological Evaluation on Vital Organs
- Author
-
Neelum Gul Qazi, Arif-ullah Khan, Sumra Wajid Abbasi, Fawad Ali Shah, Faisal Rasheed, Fawad Ali, Syed Shams ul Hassan, and Simona Bungau
- Subjects
Rumex hastatus ,antioxidant ,anti-inflammatory ,anti-ulcer ,H+/K+-ATPase ,calcium channels ,Organic chemistry ,QD241-441 - Abstract
This present study aimed to delineate Rumex hastatus D. Don crude extract (Rh.Cr), n-Hexane, ethyl acetate, aqueous fractions (Rh.n-Hex, Rh.ETAC, Rh.Aq) and rutin for antidiarrheal, antisecretory effects, anti-spasmodic, gastrointestinal transient time, anti H. pylori, antiulcer effects, and toxicology. The preliminary phytochemical analysis of Rumex hastatus showed different phytoconstituents and shows different peaks in GC-MC chromatogram. Rumex hastatus crude extract (Rh.Cr), fractions, and rutin attributed dose-dependent (50–300 mg/kg) protection (0–100%) against castor oil-induced diarrhea and dose-dependently inhibited intestinal fluid secretions in mice. They decreased the distance traversed by charcoal in the gastrointestinal transit model in rats. In rabbit jejunum preparations, Rh.Cr and Rh.ETAC caused a concentration-dependent relaxation of both spontaneous and K+ (80 mM)-induced contractions at a similar concentration range, whereas Rh.n-Hex, rutin, and verapamil were relatively potent against K+-induced contractions and shifted the Ca2+ concentration–response curves (CRCs) to the right, Rh.Cr (0.3–1 mg/mL) and Rh.ETAC (0.1–0.3 mg/mL) shifted the isoprenaline-induced inhibitory CRCs to the left. Rh.n-Hex, Rh.ETAC and rutin showed anti-H. pylori effect, also shows an inhibitory effect against H+/K+-ATPase. Rumex hastatus showed gastroprotective and antioxidant effects. Histopathological evaluation showed improvement in cellular architecture and a decrease in the expression of inflammatory markers such as, cyclooxygenase (COX-2), tumor necrosis factor (TN,F-α) and phosphorylated nuclear factor kappa B (p-NFƙB), validated through immunohistochemistry and ELISA techniques. In RT-PCR it decreases H+/K+-ATPase mRNA levels. Rumex hastatus was found to be safe to consume up to a dose of 2000 mg/kg in a comprehensive toxicity profile. Docking studies revealed that rutin against H+/K+-ATPase pump and voltage-gated L-type calcium channel showed E-values of −8.7 and −9.4 Kcal/mol, respectively. MD simulations Molecular Mechanics Poisson Boltzmann surface area and molecular mechanics Generalized Born surface area (MMPBSA/GBSA) findings are consistent with the in-vitro, in-vivo and docking results.
- Published
- 2022
- Full Text
- View/download PDF
47. Separation of Mandelic Acid by a Reactive Extraction Method Using Tertiary Amine in Different Organic Diluents
- Author
-
Barış Kiriş, Yavuz Selim Aşçı, Muhammad Zahoor, Syed Shams ul Hassan, and Simona Bungau
- Subjects
separation ,mandelic acid ,reactive extraction ,tri-n-octylamine ,Organic chemistry ,QD241-441 - Abstract
Mandelic acid is a valuable chemical that is commonly used in the synthesis of various drugs, in antibacterial products, and as a skin care agent in cosmetics. As it is an important chemical, various methods are used to synthesize and extract this compound. However, the yields of the used processes is not significant. A dilute aqueous solution is obtained when using several production methods, such as a fermentation, etc. In this study, the reactive extraction of mandelic acid from aqueous solutions using tri-n-octylamine extractant at 298.15 K was investigated. Dimethyl phthalate (DMP), methyl isobutyl ketone (MIBK), 2-octanone, 1-octanol, n-pentane, octyl acetate, and toluene were used as diluents. The batch extraction results of the mandelic acid experiments were obtained for the development of a process design. Calculations of the loading factor (Z), distribution coefficient (D), and extraction efficiency (E%) were based on the experimental data. The highest separation yield was obtained as 98.13% for 0.458 mol.L−1 of tri-n-octylamine concentration in DMP. The overall extraction constants were analyzed for the complex of acid-amine by the Bizek approach, including K11, K12, and K23.
- Published
- 2022
- Full Text
- View/download PDF
48. Novel Isoxazole Derivative Attenuates Ethanol-Induced Gastric Mucosal Injury through Inhibition of H+/K+-ATPase Pump, Oxidative Stress and Inflammatory Pathways
- Author
-
Sidra Razzaq, Amber Mahmood Minhas, Neelum Gul Qazi, Humaira Nadeem, Arif-ullah Khan, Fawad Ali, Syed Shams ul Hassan, and Simona Bungau
- Subjects
gastric ulcer ,isoxazole ,in-silico ,anti-inflammatory ,antioxidant ,H+/K+-ATPase inhibition ,Organic chemistry ,QD241-441 - Abstract
Isoxazole derivatives are significant enough due to their wide range of pharmacological and therapeutic activities. The purpose of the current study is to use computational, in vitro, in vivo, and extensive molecular approaches to examine the possible anti-ulcer activity of 4-benzylidene-3 methyl-1,2-isoxazol-5(4H)-one (MBO). Biovia Discovery Studio visualizer (DSV) was utilized for virtual screening. A tissue antioxidant investigation, H+/K+-ATPase test, and anti-H. pylori activities were carried out. ELISA, immunohistochemistry, and PCR methods were employed for the proteome analysis. An ethanol-induced stomach ulcer model was used to examine the anti-ulcer potential in rats. The binding affinities for MBO ranged from −5.4 to −8.2 Kcal/mol. In vitro findings revealed inhibitory activity against H. pylori and the H+/K+-ATPase pump. It also enhanced levels of glutathione, catalase, and glutathione-S-transferase and reduced lipid peroxidation levels in gastric tissues of rats. In vivo results showed the gastro-protective effect of MBO (30 mg/kg) in ulcerative rat stomachs. The proteomic study revealed decreased expression of inflammatory markers (cyclooxygenase-2, p-NFkB, and TNF-α). In RT-PCR analysis, the expression levels of H+/K+-ATPase were reduced. Furthermore, ADMET (absorption, distribution, metabolism, excretion and toxicity) studies revealed that MBO has high GIT solubility and has a safer profile for cardiac toxicity. This study suggests that MBO displayed anti-ulcer potential, which may have been mediated through the inhibition of the H+/K+-ATPase pump, as well as antioxidant and anti-inflammatory pathways. It has the potential to be a lead molecule in the treatment of peptic ulcers with fewer adverse effects.
- Published
- 2022
- Full Text
- View/download PDF
49. Efficacy of 2-Hydroxyflavanone in Rodent Models of Pain and Inflammation: Involvement of Opioidergic and GABAergic Anti-Nociceptive Mechanisms
- Author
-
Faiz Ali Khan, Gowhar Ali, Khista Rahman, Yahya Khan, Muhammad Ayaz, Osama F. Mosa, Asif Nawaz, Syed Shams ul Hassan, and Simona Bungau
- Subjects
analgesia ,neuropathy ,GABAergic mechanisms ,allodynia ,hyperalgesia ,Organic chemistry ,QD241-441 - Abstract
The current work examined the pharmacological potential of a selected flavanone derivative 2-hydroxyflavanone as a promising remedy for the treatment and management of pain. The selected flavanone derivative (2-HF) was evaluated for its analgesic and anti-inflammatory potentials following standard pharmacological protocols including hot plate, acetic acid-induced writhing and tail immersion tests. Naloxone and pentylenetetrazol were used to evaluate the potential implication of GABAergic and opioidergic mechanisms. The anti-inflammatory potential of 2-HF was confirmed using carrageenan-, serotonin- and histamine-induced paw edema models as well as a xylene-induced ear edema model. Furthermore, the anti-neuropathic potential of 2-HF was tested using a cisplatin-induced neuropathic pain model. Our sample, at the tested concentrations of 15, 30 and 45 mg kg−1, showed considerable analgesic, anti-inflammatory effects, as well as efficacy against neuropathic pain. Naloxone and pentylenetetrazol at 1 and 15 mg kg−1 antagonized the anti-nociceptive activities of 2-hydroxyflavanone indicating the involvement of opioidergic and GABAergic mechanisms. In the static allodynia model, combination of gabapentin 75 mg kg−1 with 2-HF at 15, 30, 45 mg kg−1 doses exhibited considerable efficacy. In cold allodynia, 2-hydroxyflavanone, at doses of 15, 30 and 45 mg kg−1 and in combination with gabapentin (75 mg kg−1), demonstrated prominent anti-allodynic effects. The paw withdrawal latency was considerably increased in gabapentin + cisplatin treated groups. Moreover, cisplatin + 2-hydroxyflavanone 15, 30, 45 mg kg−1 showed increases in paw withdrawal latency. Likewise, considerable efficacy was observed for 2-hydroxyflavanone in thermal hyperalgesia and dynamic allodynia models. Our findings suggest that 2-hydroxyflavanone is a potential remedy for pain syndrome, possibly mediated through opioidergic and GABAergic mechanisms.
- Published
- 2022
- Full Text
- View/download PDF
50. Natural Products for Chronic Diseases: A Ray of Hope
- Author
-
Syed Shams ul Hassan, Mohamed M. Abdel-Daim, Tapan Behl, and Simona Bungau
- Subjects
n/a ,Organic chemistry ,QD241-441 - Abstract
This Special Issue includes many high advanced quality papers that focus on natural products with their potent pharmacological potential targeting various areas of diseases [...]
- Published
- 2022
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.